BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34104448)

  • 1. Clozapine-associated neutropenia following augmentation with sodium valproate.
    Jakobsen MI; Grønborg H; Hansen HV; Fink-Jensen A
    SAGE Open Med Case Rep; 2021; 9():2050313X211019791. PubMed ID: 34104448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium valproate and clozapine induced neutropenia: A case control study using register data.
    Malik S; Lally J; Ajnakina O; Pritchard M; Krivoy A; Gaughran F; Shetty H; Flanagan RJ; MacCabe JH
    Schizophr Res; 2018 May; 195():267-273. PubMed ID: 28882687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E; Taylor D
    CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
    Zheng W; Xiang YT; Yang XH; Xiang YQ; de Leon J
    J Clin Psychiatry; 2017 May; 78(5):e498-e505. PubMed ID: 28355041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-CSF mediated neutrophil augmentation in a unique case of comorbid idiopathic Parkinson's disease and treatment-resistant schizophrenia on clozapine.
    Morrow O; Gibson L; Bhamra M; David AS; Posporelis S
    Ther Adv Psychopharmacol; 2020; 10():2045125320956414. PubMed ID: 32973999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs].
    Sénéchal A; Landry P; Deschamps R; Lessard M
    Encephale; 2002; 28(6 Pt 1):567-9. PubMed ID: 12506270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
    Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine.
    Pantelis C; Adesanya A
    Aust N Z J Psychiatry; 2001 Aug; 35(4):544-5. PubMed ID: 11531743
    [No Abstract]   [Full Text] [Related]  

  • 10. Re-titration rates after clozapine-induced neutropenia or agranulocytosis: A case report and literature review.
    Boazak M; Kahn B; Cox L; Ragazino J; Goldsmith DR; Cotes RO
    Clin Schizophr Relat Psychoses; 2018 Jun; ():. PubMed ID: 29944418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L; Cazard F
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapine.
    Sperner-Unterweger B; Czeipek I; Gaggl S; Geissler D; Spiel G; Fleischhacker WW
    Br J Psychiatry; 1998 Jan; 172():82-4. PubMed ID: 9534838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine-Induced Late Agranulocytosis and Severe Neutropenia Complicated with Streptococcus pneumonia, Venous Thromboembolism, and Allergic Vasculitis in Treatment-Resistant Female Psychosis.
    Voulgari C; Giannas R; Paterakis G; Kanellou A; Anagnostopoulos N; Pagoni S
    Case Rep Med; 2015; 2015():703218. PubMed ID: 25755670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.
    Matsui K; Ishibashi M; Kawano M; Oshibuchi H; Ishigooka J; Nishimura K; Inada K
    Hum Psychopharmacol; 2020 Jul; 35(4):e2739. PubMed ID: 32420645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pipamperone augmentation of clozapine and sodium valproate in refractory schizophrenia: a case report.
    Paraschakis A
    Clin Neuropharmacol; 2014; 37(2):60-1. PubMed ID: 24614672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
    Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO
    Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
    Alfaro J; Berdichevsky E; Conte G; Tellez C
    Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results.
    Ahn YM; Jeong SH; Jang HS; Koo YJ; Kang UG; Lee KY; Kim YS
    Int Clin Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 15076018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.